Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Camel toe moe and Sona bag holders

<< Previous

Bullboard Posts

Next >>

Comment by Smokey1958on Jun 11, 2021 10:10pm

231 Views

Post# 33377105

RE:RE:RE:RE:RE:RE:Camel toe moe and Sona bag holders

If you actually read the original paper you will see that the viral sample in saliva is as good as or better than a nasopharyngeal sample. Of course, because you still haven't yet revealed your intent on this board you haven't bothered to do that because it might expose that.

Cheers!!!

TheeRook wrote: This is just stating the obvious, Saliva sampling is easier than NP sampling.

This does not cover the actual testing of the Saliva sample. Which SONA found out is not so easy and why the first test were NP tests , then shallow nasal sampling.

Smokey1958 wrote:
The problem is not with saliva as a sample but in the tests themselves. With all the news out by THRM ...they have met the challenge!!!

The following is from a Canadian study done at McGill University and published in January.

“Nasopharyngeal swabs are very sensitive, but they are time-consuming and require a trained health professional to administer. Saliva-based samples are as sensitive and much cheaper, while having the advantage of being self-collected. This removes the need for a trained health professional and reduces exposure risk,” explains the corresponding author of the study, Jonathon Campbell, a Postdoctoral Fellow at the RI-MUHC. “Adopting saliva-based sampling could free up much-needed health professionals for clinical care and vaccine administration, while maintaining the high level of testing necessary to keep up with the COVID-19 pandemic.”

https://muhc.ca/news-and-patient-stories/releases/saliva-samples-covid-19-testing-good-nasopharyngeal-swabs-cheaper

TheeRook wrote: Read about the difficulties of Saliva testing. Then read how the companies / groups that test Saliva overcame the problems of testing Saliva.

THRM does not give much into how they are doing it.
BUt all these companies indicate U can not test saliva directly with any consistency which SONA found out.

BC Health Swish and Gargle Saliva test gives some good color on it.
CODX - CO DIAGNOSTICS has been testing Saliva since the beginning of Covid19
Saliva Direct - Yale School of Public Health

Chrisvaughan wrote: These saliva tests i would think are all based on the same science I would think, I have shsres here but sonas news has me rethinking